Clinical and Applied Thrombosis/Hemostasis
Journal Highlights
- Impact Factor: 2.3.512
- Indexed In: Clarivate Analytics: Science Citation Index, PubMed/MEDLINE, PubMed Central
- Publication is subject to payment of an article processing charge (APC)
- Submit here
Clinical and Applied Thrombosis/Hemostasis (CATH) is a peer-reviewed open access journal which focuses on the practical clinical and laboratory issues involved in managing bleeding and clotting disorders, especially those related to thrombosis, hemostasis, and vascular disorders. Please see the Aims and Scope tab for further information.
This journal is a member of the Committee on Publication Ethics (COPE).
This journal flipped to open access on August 1, 2017.
Submission information
Submit your manuscript today at https://mc.manuscriptcentral.com/cath.
Please see the Submission Guidelines tab for more information on how to submit your article to the journal.
Open access article processing charge (APC) information
Publication in the journal is subject to payment of an article processing charge (APC). The APC serves to support the journal and ensures that articles are freely accessible online in perpetuity under a Creative Commons license.
The APC for this journal is currently 2800 USD.
The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here.
Contact
Please direct any queries to sheilaplatt@optonline.net or erin.obrien@sagepub.com.
Other information
This journal changed its publication mode from subscription to open access in 2018.
Clinical and Applied Thrombosis/Hemostasis (CATH) is an open access, peer reviewed journal which is dedicated to serving as a forum for studies regarding the etiology, pathophysiology, clinical diagnosis, laboratory diagnosis, and treatment of thrombohemorrhagic disorders.
Articles dealing with new diagnostic procedures are encouraged, provided they are clinically oriented or potentially applicable to clinical and laboratory medicine. Articles dealing with all aspects of thrombosis, hemostasis, and vascular disorders of clinical or clinical laboratory applicability are also encouraged. The contents of the journal appeal to any person interested in clinical and applied thrombohemorrhagic disorders.
| Charles A. Carter, PharmD, MBA | Campbell University, Buies Creek, NC, USA |
| Jawed Fareed, Ph.D | Loyola University Chicago, USA |
| Hua He | Beijing Anzhen Hospital, China |
| Deborah Hoppensteadt, Ph.D | Loyola University Chicago, USA |
| Patrick Iversen, PhD | |
| Walter Jeske, Ph.D | Loyola University Medical Center, Maywood, IL, USA |
| Bulent Kantarcioglu, MD | Loyola University Chicago, USA |
| Qing Ma, PharmD, PhD | University at Buffalo, Buffalo, NY, USA |
| Charles “Kurt” Mahan, PharmD, PhC, FCCP, FASHP | University of New Mexico, Albuquerque, NM, USA |
| Wolfgang Miesbach | Universitätsklinikum Frankfurt, Germany |
| Renu Saxena | |
| Hideo Wada, M.D. | Mie University, Japan |
| Jeanine M. Walenga, Ph.D | Loyola University Medical Center, Maywood, IL, USA |
| Raul Altman, M.D. | Buenos Aires, Argentina |
| H. Peter Bacher, M.D., Ph.D | Long Grove, IL, USA |
| Gianni Belcaro, M.D., Ph.D | Pelcara, Italy |
| Samuel Berkman, M.D., FACP | Bevery Hills, CA, USA |
| Genmao Cao, M.D. | Shanxi Medical University, Taiyuan, China |
| Anthony K. Chan | McMaster University, Canada |
| Sergio Coccheri | Bologna, Italy |
| Muzaffer Demir, M.D. | Trakya University, Turkey |
| Thao T. Doan, MD | AbbVie Inc., North Chicago, IL, USA |
| Esteban Gandara | The Ottowa Hospital, General Campus, Canada |
| Antonio Girolami, M.D. | University of Padua, Italy |
| Charles J. Glueck, M.D. | Cholesterol Center, ABC Building |
| Sylvia Haas, MD | Munich, Germany |
| Mohammad Jamshidi, DO, FACS | Millennia Care Clinic, TX, USA |
| Nicos Labropoulos | Stony Brook University Medical Center, Stony Brook, NY, USA |
| Valery Leytin, Ph.D | St. Michael’s Hospital, Toronto, Canada |
| Fabio Lievano, MD | AbbVie Inc., North Chicago, IL, USA |
| Charles “Kurt” Mahan, PharmD, PhC, FCCP, FASHP | University of New Mexico, Albuquerque, NM, USA |
| Dimitri P. Mikhailidis, M.D., FRCPATH | London, England, UK |
| Michael Mosesson, M.D. | University of Wisconsin, USA |
| Andrew N. Nicolaides | London, UK |
| William F. Pope | Dallas, TX, USA |
| Eduardo Ramacciotti, MD, PhD | Hospital e Maternidade Dr Christóvão da Gama, Sao Paulo, Brazil |
| Rachel Ryu, PharmD, BCPS | Western University of Health Sciences, Pomona, CA, USA |
| Arthur Sasahara, M.D. | Boston, MA, USA |
| Georg-Friedrich von Tempelhoff, M.D. | City Hospital of Ruesselshein, Germany |
| David H. Van Thiel, M.D. |
| Russell D. Hull, MBBS, MSc, FRCP(C), PACP | Alberta, Canada |
| Mehmet Baysal, MD | Hematology Department Tekirdag I. Fehmi Cumalioglu City Hospital, Turkey |
| Giovanni Merlino, MD PhD. | Udine University Hospital, Udine, Italy |
| Despoina Pantazi, MSc, PhD | University of Ioannina, Greece |
| Rafael de Athayde Soares, Phd, M.D. | Instituto de assistência médica ao servidor público estadual de São Paulo (Iamspe)/ São Paulo - SP |
Manuscript submission guidelines can be accessed on Sage Journals.